Compare BSX & PSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSX | PSX |
|---|---|---|
| Founded | 1979 | 1875 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.8B | 68.8B |
| IPO Year | 2010 | 2011 |
| Metric | BSX | PSX |
|---|---|---|
| Price | $49.34 | $203.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 22 | 19 |
| Target Price | $93.18 | ★ $165.63 |
| AVG Volume (30 Days) | ★ 17.9M | 2.4M |
| Earning Date | 04-22-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.93% |
| EPS Growth | 55.20 | ★ 116.23 |
| EPS | 1.51 | ★ 10.05 |
| Revenue | $9,076,000,000.00 | ★ $132,376,000,000.00 |
| Revenue This Year | $11.85 | $15.71 |
| Revenue Next Year | $10.16 | N/A |
| P/E Ratio | $32.65 | ★ $20.45 |
| Revenue Growth | ★ 12.49 | N/A |
| 52 Week Low | $42.20 | $118.07 |
| 52 Week High | $109.50 | $216.08 |
| Indicator | BSX | PSX |
|---|---|---|
| Relative Strength Index (RSI) | 64.48 | 58.45 |
| Support Level | $47.17 | $200.80 |
| Resistance Level | $50.14 | $216.08 |
| Average True Range (ATR) | 1.60 | 6.66 |
| MACD | 0.69 | -1.33 |
| Stochastic Oscillator | 88.77 | 33.04 |
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Phillips 66 is an independent refiner that owns or holds interest in 10 refineries with a total crude throughput capacity of 2.0 million barrels per day, or mmb/d, at the end of 2025. The midstream segment comprises extensive transportation and NGL processing assets. It includes 70,000 miles of crude oil, refined petroleum product, NGL and natural gas pipeline systems, and a comprehensive set of refined petroleum product, NGL and crude oil terminals, gathering and processing plants and fractionation facilities and various other storage and loading facilities. Its CPChem chemical joint venture operates facilities primarily in the United States and the Middle East and produces olefins and polyolefins.